Camber Pharmaceuticals Launches Generic Gralise®
Camber Pharmaceuticals is pleased to announce the addition of Gabapentin Tablets (generic for Gralise®) to its current portfolio. Camber already offers Gabapentin Tablets and Capsules (generic for Neurontin®). Generics for Gralise® and Neurontin® are not interchangeable.
Gabapentin Tablets (generic for Gralise®) are indicated for the management of Postherpetic Neuralgia (PHN).
Gabapentin Tablets (generic for Gralise®) 300 mg and 600 mg are available in 90 count bottles.
To find out more about Gabapentin Tablets, please visit https://www.camberpharma.com/gabapentintablets-gralise
Recent articles
- New Product Launch: Clomiphene Citrate Tablets, USP
- Camber Launches Raltegravir Tablets 400 mg
- Specialty Generics: Where Access Meets Affordability
- Buprenorphine and Naloxone Sublingual Films Added to Portfolio
- Buprenorphine and Naloxone Sublingual Tablets Added to Portfolio
- New to Camber’s Portfolio: Losartan Potassium and Hydrochlorothiazide Tablets





